Sars-cov-2 mrna-1273 (6m-5y) vaccine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with sars-cov-2 mrna-1273 (6m-5y) vaccine
J
- Jakafi (ruxolitinib)
- japanese enceph vacc sa14-14-2, inactivated
- japanese encephalitis virus vaccine nakayama
- Jaypirca (pirtobrutinib)
- Je-Vax (japanese encephalitis virus vaccine nakayama)
- Jelmyto (mitomycin)
- Jevtana (cabazitaxel)
- Joenja (leniolisib)
- Juvederm Ultra Plus XC (hyaluronan / lidocaine)
- Jylamvo (methotrexate)
- Jynneos (smallpox and monkeypox vaccine)
More about sars-cov-2 mrna-1273 (6m-5y) vaccine
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.